Novavax is part of the FDA's COVID-19 booster debate, but its vaccine still hasn't been authorized - MarketWatch

Novavax is part of the FDA's COVID-19 booster debate, but its vaccine still hasn't been authorized - MarketWatch: The experimental shot played a front-and-center role during this week’s debate about how best to update the COVID-19 vaccines to better protect against omicron.